About Cassava Sciences (SAVA)
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead... Read more
- USD21.23
- USD21.94
- USD20.77
- USD32.10
- -0.10%
- --
- 979.00
- 958.18k
- 984M
- 12.32
- -13.90%
Stock News
6 hours ago
Google is combining its Android software and Pixel hardware divisions to more broadly integrate AI
Yahoo
7 hours ago
American Express’s Profits Expected to Rise as Investors Monitor Signs of Slowdown
Yahoo
7 hours ago
Intuitive Surgical (ISRG) Q1 2024 Earnings Call Transcript
Yahoo
8 hours ago
MSCI Inc.: Here's Why I Bought This Stock With Double-Digit Dividend Growth Potential
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
